FDA clears first fully disposable duodenoscope, eliminating the potential for infections caused by ineffective reprocessing

The U.S. Food and Drug Administration today cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct...

Webinar Addresses ‘Hot Topic’

The recent OR Today webinar “Human Factors and Quality Testing for Device Reprocessing” was sponsored by Healthmark and eligible for one (1) continuing education (CE) hour by the State of California Board of Registered Nursing. The 60-minute webinar featured Jahan...

Nihon Kohden Introduces First Subscription-Based Pricing for Patient Monitoring, Neurology Products

Nihon Kohden, a U.S. market leader in precision medical products and services, has launched subscription-based pricing models for its patient monitoring and neurology products, the first in the industry to take such a step. The pricing models help align costs with...

Nihon Kohden Launches Life Scope SVM-7200 Series

Nihon Kohden has announced the launch of its Life Scope SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds that traditionally are not continuously monitored. The monitor allows health care practitioners to quickly and easily...

A Systematic Approach to Adopting New Technologies for the Sterile Processing Department (SPD) and Operating Room (OR)

Technological advancements in the health care field are critically important, as they can both lengthen and improve quality of life.

Despite the potentially significant benefits of implementing new advancements immediately, health care facilities often delay implementation as they await updated standards and subsequently manufacturer’s Instructions for Use (IFUs) reflecting these new technologies.

Though while still relevant, these standards remain a major impediment to the adoption of emerging technologies, including those within the realm of sterile processing. Many national standards, including those maintained by the Association for the Advancement of Medical Instruments (AAMI) and the Association of periOperative Registered Nurses (AORN), are updated on a five-year cycle.

Even standards with more frequent updates or amendments, such as the AAMI ST79 steam sterilization standards, can’t possibly keep pace with technology. The process of updating the ST79 standards requires stakeholder meetings (including manufacturers’ representatives, laboratories, federal regulatory agencies and health care workers), a public comment period, and then final adoption by the Sterilization Standards Committee. This arduous process can typically take up to three years, by which time even more advanced innovations may have come to market.

Given this gap, health care institutions need an avenue by which to evaluate and adopt newly developed products and technologies that current standards presently do not address.

Health care facilities owe it to their patients to not delay implementation of new technology or tools that can improve patient care, particularly when these advancements can do one or more of the following:

  • Enhance patient safety
  • Decrease the risk of infection transmission
  • Increase speed or improve efficiency
  • Decrease cost of care
  • Fortunately, there is an alternative to waiting until the recommended practices catch up with technological advancements: facilitating an in-house multidisciplinary risk assessment.

Rose Seavey is President/CEO of Seavey Healthcare Consulting and formerly the Director of the Sterile Processing Department at The Children’s Hospital of Denver. She served on the AORN Board in 2008-2010 and is past President ASHCSP. She serves on several AAMI committees writing national standards for reprocessing.

Find out more online at



Submit a Comment

Your email address will not be published. Required fields are marked *